Status:
COMPLETED
Airway Responses to Montelukast and Desloratadine.
Lead Sponsor:
University of Saskatchewan
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Montelukast (for asthma) and desloratadine (for allergies) are effective therapy for their current uses. Part of what happens when your allergies trigger your asthma should be prevented by either of t...
Eligibility Criteria
Inclusion
- baseline FEV1 \> or = 65% predicted
- positive methacholine challenge (i.e. methacholine PC20 \< or = 16mg/ml
- positive allergen challenge
Exclusion
- negative skin prick test
- lung condition/disease other than asthma
- currently use montelukast and/or desloratadine
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00424580
Start Date
January 1 2007
End Date
August 1 2007
Last Update
January 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Room 346 Ellis Hall
Saskatoon, Saskatchewan, Canada, S7N 0W8